drugset / Trial / NCT00125814
Structured Treatment Interruptions With or Without Pegylated Interferon Alpha for HIV-Infected Patients After Prolonged Viral Suppression
Phase 3
Terminated
200 enrolled
French National Agency for Research on AIDS and Viral Hepatitis
Schering-Plough · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether the adjunctional of interferon alfa to structured treatment interruptions correlated with a long time off treatment in HIV-1 infection.
Timeline
- Start
- 2001-12
- Primary completion
- —
- Completion
- 2005-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | interferon alfa-2b | Protein / enzyme biologic | — | — |